Open Access

Anticoagulation 3.0: the first NOAC with a reversal agent.

Topic: Thrombosis and coagulation
Sponsored by Boehringer Ingelheim

Congress Session

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

4 more presentations in this session

The future is now.

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

Anticoagulation in the electrophysiology lab: how can specific reversal simplify care?

Speaker: Doctor H. Calkins (Baltimore, US)

Thumbnail

Anticoagulation post-PCI: case based discussion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Thumbnail

Audience Q&A - The future is now: impact of oral anticoagulation reversal on your practice.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Access the full session

The future is now: impact of oral anticoagulation reversal on your practice

Speakers: Doctor J. Weitz, Professor C. Cannon, Doctor H. Calkins, Professor S. Hohnloser, Professor G. Lip
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk